NEJM Group, the publisher of the New England Journal of Medicine, is planning a new journal, NEJM AI, to identify and evaluate state-of-the-art applications of artificial intelligence to clinical medicine.
In addition to original research, NEJM AI will provide reviews, policy perspectives, and accessible educational material targeted at practicing physicians and clinician leaders interested in applying AI, computer scientists seeking to translate algorithmic advances to clinical practice, and policy makers and regulators.
The past decade has seen a resurgence of artificial intelligence (AI) in medicine enabled by new advancements in machine learning, from deep learning systems for computer vision to the latest conversational agents based on large language models.
There are FDA-approved devices that use AI to read a broad range of imaging modalities, programs that provide diagnostic assistance, and software that helps outline possible treatments and provide prognostic data for clinicians. Although many such devices have met regulatory standards, the uptake in the medical community has failed to meet expectations.
In a world where life expectancy continues to increase, the concept of longevity no longer…
The Korea Institute of Dermatological Sciences has been conducting safety and efficacy evaluations, in-vitro evaluations,…
CLAIM® is an Argentina-based Contract Research Organization (CRO) specializing in the design, development, and execution…